Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone
Bosch-Barrera J., Espinós J., Gómez-Ibáñez A., Gállego Pérez-Larraya J., Iriarte J.
Ixabepilone is a novel microtubule-stabilising agent used as monotherapy or in combination with capecitabine to treat taxane- and anthracycline-refractory breast cancer.
We report the case of a patient who experienced an unusual motor neuropathy after the first cycle. This is a very uncommon secondary effect, but it must be taken into account as a possible complication of treatment with ixabepilone.
CITATION Clin Transl Oncol. 2009 Nov;11(11):765-7